Goldman Sachs
AVEO

Goldman Sachs’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-642,652
Closed -$9.61M 5498
2022
Q4
$9.61M Buy
642,652
+584,788
+1,011% +$8.74M ﹤0.01% 2164
2022
Q3
$476K Buy
57,864
+36,797
+175% +$303K ﹤0.01% 4285
2022
Q2
$138K Buy
21,067
+5,889
+39% +$38.6K ﹤0.01% 5016
2022
Q1
$85K Sell
15,178
-242,930
-94% -$1.36M ﹤0.01% 5357
2021
Q4
$1.21M Sell
258,108
-23,559
-8% -$111K ﹤0.01% 3879
2021
Q3
$1.74M Sell
281,667
-61,175
-18% -$378K ﹤0.01% 3592
2021
Q2
$2.26M Buy
342,842
+299,239
+686% +$1.97M ﹤0.01% 3412
2021
Q1
$319K Buy
43,603
+1,523
+4% +$11.1K ﹤0.01% 4611
2020
Q4
$243K Sell
42,080
-69,527
-62% -$401K ﹤0.01% 4179
2020
Q3
$663K Buy
111,607
+39,038
+54% +$232K ﹤0.01% 3525
2020
Q2
$374K Buy
+72,569
New +$374K ﹤0.01% 3729
2020
Q1
Sell
-44,880
Closed -$28K 4643
2019
Q4
$28K Sell
44,880
-32,904
-42% -$20.5K ﹤0.01% 4237
2019
Q3
$65K Sell
77,784
-272,788
-78% -$228K ﹤0.01% 4100
2019
Q2
$236K Buy
350,572
+322,484
+1,148% +$217K ﹤0.01% 3807
2019
Q1
$23K Sell
28,088
-53,548
-66% -$43.8K ﹤0.01% 4130
2018
Q4
$131K Buy
81,636
+12,020
+17% +$19.3K ﹤0.01% 3846
2018
Q3
$231K Buy
69,616
+49,931
+254% +$166K ﹤0.01% 3767
2018
Q2
$44K Sell
19,685
-762,645
-97% -$1.7M ﹤0.01% 4073
2018
Q1
$2.27M Buy
782,330
+541,395
+225% +$1.57M ﹤0.01% 2810
2017
Q4
$672K Buy
+240,935
New +$672K ﹤0.01% 3313
2017
Q3
Sell
-13,732
Closed -$30K 4494
2017
Q2
$30K Buy
+13,732
New +$30K ﹤0.01% 4305
2016
Q4
Sell
-16,931
Closed -$15K 4625
2016
Q3
$15K Buy
+16,931
New +$15K ﹤0.01% 4473
2016
Q1
Sell
-18,995
Closed -$24K 4672
2015
Q4
$24K Sell
18,995
-55,958
-75% -$70.7K ﹤0.01% 4326
2015
Q3
$91K Buy
74,953
+5,967
+9% +$7.24K ﹤0.01% 4202
2015
Q2
$120K Sell
68,986
-118,851
-63% -$207K ﹤0.01% 4252
2015
Q1
$272K Buy
187,837
+49,632
+36% +$71.9K ﹤0.01% 3710
2014
Q4
$116K Sell
138,205
-56,892
-29% -$47.8K ﹤0.01% 4212
2014
Q3
$217K Buy
195,097
+46
+0% +$51 ﹤0.01% 3893
2014
Q2
$357K Sell
195,051
-25,333
-11% -$46.4K ﹤0.01% 3564
2014
Q1
$329K Sell
220,384
-24,064
-10% -$35.9K ﹤0.01% 3630
2013
Q4
$447K Buy
244,448
+110,658
+83% +$202K ﹤0.01% 3482
2013
Q3
$275K Buy
133,790
+46,855
+54% +$96.3K ﹤0.01% 3664
2013
Q2
$217K Buy
+86,935
New +$217K ﹤0.01% 3594